184 related articles for article (PubMed ID: 32368080)
1. Sinomenine Inhibits Non-Small Cell Lung Cancer via Downregulation of Hexokinases II-Mediated Aerobic Glycolysis.
Liu W; Yu X; Zhou L; Li J; Li M; Li W; Gao F
Onco Targets Ther; 2020; 13():3209-3221. PubMed ID: 32368080
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol inhibits Hexokinases II mediated glycolysis in non-small cell lung cancer via targeting Akt signaling pathway.
Li W; Ma X; Li N; Liu H; Dong Q; Zhang J; Yang C; Liu Y; Liang Q; Zhang S; Xu C; Song W; Tan S; Rong P; Wang W
Exp Cell Res; 2016 Dec; 349(2):320-327. PubMed ID: 27829129
[TBL] [Abstract][Full Text] [Related]
3. Deguelin inhibits non-small cell lung cancer via down-regulating Hexokinases II-mediated glycolysis.
Li W; Gao F; Ma X; Wang R; Dong X; Wang W
Oncotarget; 2017 May; 8(20):32586-32599. PubMed ID: 28427230
[TBL] [Abstract][Full Text] [Related]
4. Repression of Hexokinases II-Mediated Glycolysis Contributes to Piperlongumine-Induced Tumor Suppression in Non-Small Cell Lung Cancer Cells.
Zhou L; Li M; Yu X; Gao F; Li W
Int J Biol Sci; 2019; 15(4):826-837. PubMed ID: 30906213
[TBL] [Abstract][Full Text] [Related]
5. miR-206 regulates non-small-cell lung cancer cell aerobic glycolysis by targeting hexokinase 2.
Jia KG; Feng G; Tong YS; Tao GZ; Xu L
J Biochem; 2020 Apr; 167(4):365-370. PubMed ID: 31742336
[TBL] [Abstract][Full Text] [Related]
6. Hexokinases II-mediated glycolysis governs susceptibility to crizotinib in ALK-positive non-small cell lung cancer.
Lin C; Chen H; Han R; Li L; Lu C; Hao S; Wang Y; He Y
Thorac Cancer; 2021 Dec; 12(23):3184-3193. PubMed ID: 34729938
[TBL] [Abstract][Full Text] [Related]
7. Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis.
Liu W; Li W; Liu H; Yu X
Int J Biol Sci; 2019; 15(11):2497-2508. PubMed ID: 31595166
[TBL] [Abstract][Full Text] [Related]
8. TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2.
He R; Liu H
Gene; 2020 Jul; 747():144553. PubMed ID: 32165307
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.
Zhang K; Zhang M; Jiang H; Liu F; Liu H; Li Y
Biomed Pharmacother; 2018 Sep; 105():545-552. PubMed ID: 29886375
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of EGFR Signaling and Activation of Mitochondrial Apoptosis Contribute to Tanshinone IIA-Mediated Tumor Suppression in Non-Small Cell Lung Cancer Cells.
Gao F; Li M; Liu W; Li W
Onco Targets Ther; 2020; 13():2757-2769. PubMed ID: 32308411
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis.
Li M; Gao F; Zhao Q; Zuo H; Liu W; Li W
Cell Death Dis; 2020 May; 11(5):381. PubMed ID: 32424132
[TBL] [Abstract][Full Text] [Related]
12. Erianin promotes apoptosis and inhibits Akt-mediated aerobic glycolysis of cancer cells.
Han S; Chen S; Wang J; Huang S; Xiao Y; Deng G
J Cancer; 2024; 15(8):2380-2390. PubMed ID: 38495480
[TBL] [Abstract][Full Text] [Related]
13. Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer.
Kim S; Jang JY; Koh J; Kwon D; Kim YA; Paeng JC; Ock CY; Keam B; Kim M; Kim TM; Heo DS; Chung DH; Jeon YK
J Exp Clin Cancer Res; 2019 Nov; 38(1):462. PubMed ID: 31718692
[TBL] [Abstract][Full Text] [Related]
14. PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma.
Zhuo B; Li Y; Li Z; Qin H; Sun Q; Zhang F; Shen Y; Shi Y; Wang R
Biochem Biophys Res Commun; 2015 Aug; 464(2):401-6. PubMed ID: 26116768
[TBL] [Abstract][Full Text] [Related]
15. Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.
Wu J; Zhang X; Wang Y; Sun Q; Chen M; Liu S; Zou X
Oncol Rep; 2018 Mar; 39(3):1181-1190. PubMed ID: 29286170
[TBL] [Abstract][Full Text] [Related]
16. CircLARP4 Suppresses Cell Proliferation, Invasion and Glycolysis and Promotes Apoptosis in Non-Small Cell Lung Cancer by Targeting miR-135b.
Lu H; Guo Q; Mao G; Zhu J; Li F
Onco Targets Ther; 2020; 13():3717-3728. PubMed ID: 32440141
[TBL] [Abstract][Full Text] [Related]
17. A causal link from ALK to hexokinase II overexpression and hyperactive glycolysis in EML4-ALK-positive lung cancer.
Ma Y; Yu C; Mohamed EM; Shao H; Wang L; Sundaresan G; Zweit J; Idowu M; Fang X
Oncogene; 2016 Nov; 35(47):6132-6142. PubMed ID: 27132509
[TBL] [Abstract][Full Text] [Related]
18. [miR-181c inhibits glycolysis by targeting hexokinase 2 in cancer-associated fibroblasts].
Lan H; Luo L; Qi X; Gong Y; Chen Y
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Nov; 35(11):1619-23. PubMed ID: 26607087
[TBL] [Abstract][Full Text] [Related]
19. Jolkinolide B inhibits glycolysis by downregulating hexokinase 2 expression through inactivating the Akt/mTOR pathway in non-small cell lung cancer cells.
Gao X; Han H
J Cell Biochem; 2018 Jun; 119(6):4967-4974. PubMed ID: 29384225
[TBL] [Abstract][Full Text] [Related]
20. Xanthohumol suppresses glioblastoma via modulation of Hexokinase 2 -mediated glycolysis.
Yuan J; Peng G; Xiao G; Yang Z; Huang J; Liu Q; Yang Z; Liu D
J Cancer; 2020; 11(14):4047-4058. PubMed ID: 32368287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]